Unidad de Investigación Clínica Farmacocinética FP Clinical Pharma en Clínica CIAREC
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
YERINO, Gustavo A
ARVAC-F2/3-002, NCT05752201: ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

Completed
2/3
2014
RoW
Gamma Variant RBD-based ARVAC-CG vaccine, Omicron Variant RBD-based ARVAC-CG vaccine, Bivalent RBD-based ARVAC-CG vaccine, Placebo (Alum)
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno, Universidad Nacional de San Martín (UNSAM), National Council of Scientific and Technical Research, Argentina, Laboratorio Pablo Cassará S.R.L.
COVID-19 Vaccine
08/23
12/23
NCT05656508: ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

Completed
1
80
RoW
ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2)
Laboratorio Pablo Cassara S.R.L., Universidad Nacional de San Martín (UNSAM), National Council of Scientific and Technical Research, Argentina
COVID-19 Vaccine
09/22
10/23

Download Options